Cargando…
Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies
Playing critical roles in immune responses, interleukin-6 (IL-6) has been proposed to be involved in the development of multiple cancers, including prostate cancer. The rs1800795 polymorphism in the promoter of the gene IL-6 can affect the transcription and expression of the gene, becoming a common...
Autores principales: | Liu, Tong-Zu, Guo, Zhong-Qiang, Wang, Ting, Cao, Yue, Huang, Di, Wang, Xing-Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369879/ https://www.ncbi.nlm.nih.gov/pubmed/28296724 http://dx.doi.org/10.1097/MD.0000000000006126 |
Ejemplares similares
-
Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications
por: Fang, Cheng, et al.
Publicado: (2017) -
Association of 17q24 rs1859962 gene polymorphism with prostate cancer risk: A systematic review and meta-analysis
por: Ren, Feiqiang, et al.
Publicado: (2020) -
Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis
por: Liu, Jinnian, et al.
Publicado: (2021) -
Association of IL-6 -174G>C (rs1800795) polymorphism with cervical cancer susceptibility
por: Duan, Hai-Xia, et al.
Publicado: (2018) -
The IL-6 rs1800795 and rs1800796 polymorphisms are associated with coronary artery disease risk
por: Lu, Shuai, et al.
Publicado: (2020)